Skip to main content
Article
Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design
British Journal of Haematology (2014)
  • Jack M. Lionberger, Saint Louis University
  • John M. Pagel, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Vicky K. Sandhu, Fred Hutchinson Cancer Research Center
  • Hu Xie, Fred Hutchinson Cancer Research Center
  • Mazyar Shadman, University of Washington
  • Mazyar Shadman, Fred Hutchinson Cancer Research Center
  • Raya Mawad, University of Washington
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Alexandra Boehm, Fred Hutchinson Cancer Research Center
  • Carol Dean, Fred Hutchinson Cancer Research Center
  • Kathleen Shannon-Dorcy, Fred Hutchinson Cancer Research Center
  • Bart L. Scott, University of Washington
  • Bart L. Scott, Fred Hutchinson Cancer Research Center
  • Hans Joachim Deeg, University of Washington
  • Hans Joachim Deeg, Fred Hutchinson Cancer Research Center
  • Pamela S. Becker, University of Washington
  • Pamela S. Becker, Fred Hutchinson Cancer Research Center
  • Paul C. Hendrie, University of Washington
  • Paul C. Hendrie, Fred Hutchinson Cancer Research Center
  • Roland B. Walter, University of Washington
  • Roland B. Walter, Fred Hutchinson Cancer Research Center
  • Fabiana Ostronoff, University of Washington
  • Fabiana Ostronoff, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, University of Washington
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Elihu H. Estey, University of Washington
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
Publication Date
August 1, 2014
DOI
10.1111/bjh.12905
Citation Information
Jack M. Lionberger, John M. Pagel, John M. Pagel, Vicky K. Sandhu, et al.. "Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design" British Journal of Haematology Vol. 166 Iss. 3 (2014) p. 375 - 381
Available at: http://works.bepress.com/john-pagel/310/